home / stock / gnta / gnta news

GNTA News and Press, Genenta Science S.p.A. From 03/09/22

Stock Information
Company Name: Genenta Science S.p.A.
Stock Symbol: GNTA
Market: NASDAQ
Website: genenta.com
Menu
GNTA GNTA Quote GNTA Short GNTA News GNTA Articles GNTA Message Board
Get GNTA Alerts

News, Short Squeeze, Breakout and More Instantly...
GNTA - Genenta Data Presentation at AACR to Describe On-Target Biological Activity of Temferon(TM) in Unmethylated Glioblastoma Multiforme

MILAN, Italy and NEW YORK, March 09, 2022 (GLOBE NEWSWIRE) -- Genenta Science (NASDAQ: GNTA), a clinical-stage biotechnology company pioneering the development of hematopoietic stem progenitor cell immuno-gene therapy for cancer, will present clinical data from its Phase 1/2a dose-escalatio...
GNTA - Genenta to Participate at Upcoming Investor Conferences

MILAN, Italy and NEW YORK, Feb. 24, 2022 (GLOBE NEWSWIRE) -- Genenta Science (NASDAQ: GNTA), a clinical-stage biotechnology company pioneering the development of hematopoietic stem progenitor cell immuno-gene therapy for cancer (Temferon™), announced today that management will be par...

GNTA - Genenta Science (NASDAQ: GNTA) Featured in Virtual Coverage of the 34th Annual Roth Conference

Genenta Science (NASDAQ: GNTA) is a clinical-stage biotechnology company pioneering the development of a proprietary hematopoietic stem cell gene therapy for the treatment of a variety of solid tumor cancers. Temferon(TM) is based on ex-vivo gene transfer into autologous hematopoietic...

GNTA - InvestorNewsBreaks - Genenta Science S.p.A. (NASDAQ:GNTA) Announces Completion of $36 Million IPO

Genenta Science (NASDAQ:GNTA) , a clinical-stage biotechnology company pioneering the development of hematopoietic stem progenitor cell immuno-gene therapy for solid tumors, including the lead product candidate, Temferon(TM), has closed on its upsized initial public offering. The offering w...
GNTA - U.S. IPO Weekly Recap: 6 IPOs Debut Ahead Of The Shortened Holiday Week

The IPO market saw an uptick in activity this past week with six IPOs raising $919 million, led by IoT solutions developer Samsara. 14 SPACs also went public. The pipeline got a boost, with six IPOs and three SPACs submitting initial filings. For further details see: U.S...

GNTA - Genenta Closes Its Upsized Initial Public Offering of American Depository Shares

MILAN, Italy and NEW YORK, Dec. 17, 2021 (GLOBE NEWSWIRE) -- Genenta Science S.p.A. (Nasdaq: GNTA), a clinical-stage biotechnology company pioneering the development of hematopoietic stem progenitor cell immuno-gene therapy for solid tumors, including the lead product candidate, Temferon&#x...

Previous 10 Next 10